Weis Markets Q2 Revenue Climbs 4.6%, but Net Income Drops 9.6% on Pharmacy Headwinds
WMK sits 28% above its 52-week low of $59.99.
Summary
Weis Markets posted Q2 2026 revenue of $1.28 billion (+4.6%) and EPS of $0.92 (-4.2% YoY), as pharmacy pricing headwinds and stepped-up promotions weighed on profits.
Key Events · Earnings and Guidance · WMK
-
Q2 Revenue Growth
Total revenue rose 4.6% to $1.28 billion, with comparable store sales up 2.3% year-over-year.
-
Net Income Decline
Second quarter net income fell 9.6% to $22.86 million, or $0.92 per share, compared to $25.28 million ($0.96 per share) a year ago.
-
Pharmacy Headwinds
Pharmacy revenue was negatively impacted by approximately $10.71 million from Medicare maximum fair price provisions under the Inflation Reduction Act.
-
Year-to-Date Performance
For the first half of 2026, net income increased 13.1% to $50.71 million, or $2.05 per share, on revenue of $2.53 billion.
Analysis · WMK · Trade & Services
Weis Markets turned in a mixed second quarter. While total revenue advanced 4.6% to $1.28 billion—supported by a 2.3% gain in comparable store sales—net income contracted 9.6% to $22.86 million. The profit squeeze reflects heavier promotional spending and a $10.7 million pharmacy revenue headwind tied to Medicare drug pricing reforms. On a year-to-date basis, net income is up 13.1%, buoyed by a stronger first quarter. The company also declared a $0.34 quarterly dividend, in line with prior payouts. This release offers the first clear view of how inflation and regulatory changes are shaping the grocery chain's profitability.
At the time of this filing, WMK was trading at $76.80 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $59.99 to $83.74. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.